Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IMMUNOCORE HOLDINGS PLC

(IMCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Immunocore Posts Narrower Q3 Loss, Lower Revenue

11/10/2021 | 08:28am EST


ę MT Newswires 2021
All news about IMMUNOCORE HOLDINGS PLC
01/27Immunocore Wins US FDA Nod for Skin Cancer Drug
MT
01/26IMMUNOCORE : announces FDA approval of KIMMTRAK« (tebentafusp-tebn) for the treatment of u..
PU
01/26Health Care Stocks Catching Up With Late Market Declines
MT
01/26Health Care Stocks Putting Up Modest Gains
MT
01/26Health Care Stocks Climb Premarket Wednesday
MT
01/26Health Care
MT
01/26Top Premarket Gainers
MT
01/26Immunocore Holdings Says it Gets FDA Approval for Rare Cancer Treatment; Shares Jump Pr..
MT
01/26Immunocore Gets FDA OK of Kimmtrak in Uveal Melanoma
DJ
01/26Immunocore announces FDA approval of KIMMTRAK« (tebentafusp-tebn) for the treatment of ..
GL
More news
Analyst Recommendations on IMMUNOCORE HOLDINGS PLC
More recommendations
Financials
Sales 2021 26,0 M 34,8 M 34,8 M
Net income 2021 -127 M -170 M -170 M
Net cash 2021 191 M 255 M 255 M
P/E ratio 2021 -5,22x
Yield 2021 -
Capitalization 679 M 909 M 909 M
EV / Sales 2021 18,8x
EV / Sales 2022 16,5x
Nbr of Employees 291
Free-Float 73,4%
Chart IMMUNOCORE HOLDINGS PLC
Duration : Period :
Immunocore Holdings plc Technical Analysis Chart | IMCR | US45258D1054 | MarketScreener
Technical analysis trends IMMUNOCORE HOLDINGS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1 549,31 GBX
Average target price 3 557,85 GBX
Spread / Average Target 130%
EPS Revisions
Managers and Directors
Bahija Jallal Chief Executive Officer & Director
Brian R. DiDonato Chief Financial Officer & Head-Strategy
David Berman Head-Research & Development
Roy Steven Herbst Non-Executive Director
John Irving Bell Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
IMMUNOCORE HOLDINGS PLC-39.43%909
MODERNA, INC.-41.48%60 258
LONZA GROUP AG-19.46%48 939
IQVIA HOLDINGS INC.-17.77%44 321
SEAGEN INC.-20.50%22 475
ICON PUBLIC LIMITED COMPANY-17.13%20 892